EP3201624A4 - Dispositif, système et procédé de détection d'hémolyse - Google Patents

Dispositif, système et procédé de détection d'hémolyse Download PDF

Info

Publication number
EP3201624A4
EP3201624A4 EP15846601.1A EP15846601A EP3201624A4 EP 3201624 A4 EP3201624 A4 EP 3201624A4 EP 15846601 A EP15846601 A EP 15846601A EP 3201624 A4 EP3201624 A4 EP 3201624A4
Authority
EP
European Patent Office
Prior art keywords
detection device
hemolysis detection
hemolysis
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP15846601.1A
Other languages
German (de)
English (en)
Other versions
EP3201624B1 (fr
EP3201624A1 (fr
Inventor
Andrew John Baxter
Paul William Cotton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Priority to EP24196993.0A priority Critical patent/EP4465017A3/fr
Priority to EP20160334.7A priority patent/EP3686597B1/fr
Publication of EP3201624A1 publication Critical patent/EP3201624A1/fr
Publication of EP3201624A4 publication Critical patent/EP3201624A4/fr
Application granted granted Critical
Publication of EP3201624B1 publication Critical patent/EP3201624B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/04—Investigating sedimentation of particle suspensions
    • G01N15/05—Investigating sedimentation of particle suspensions in blood
    • G01N2015/055—Investigating sedimentation of particle suspensions in blood for hematocrite determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP15846601.1A 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse Active EP3201624B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP24196993.0A EP4465017A3 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse
EP20160334.7A EP3686597B1 (fr) 2014-09-30 2015-09-29 Système de détermination de la quantité d'hémoglobine dans une fraction plasmatique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462057452P 2014-09-30 2014-09-30
PCT/US2015/052926 WO2016054030A1 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP24196993.0A Division EP4465017A3 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse
EP20160334.7A Division EP3686597B1 (fr) 2014-09-30 2015-09-29 Système de détermination de la quantité d'hémoglobine dans une fraction plasmatique

Publications (3)

Publication Number Publication Date
EP3201624A1 EP3201624A1 (fr) 2017-08-09
EP3201624A4 true EP3201624A4 (fr) 2017-08-30
EP3201624B1 EP3201624B1 (fr) 2020-03-11

Family

ID=55631357

Family Applications (3)

Application Number Title Priority Date Filing Date
EP20160334.7A Active EP3686597B1 (fr) 2014-09-30 2015-09-29 Système de détermination de la quantité d'hémoglobine dans une fraction plasmatique
EP15846601.1A Active EP3201624B1 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse
EP24196993.0A Pending EP4465017A3 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20160334.7A Active EP3686597B1 (fr) 2014-09-30 2015-09-29 Système de détermination de la quantité d'hémoglobine dans une fraction plasmatique

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP24196993.0A Pending EP4465017A3 (fr) 2014-09-30 2015-09-29 Dispositif, système et procédé de détection d'hémolyse

Country Status (6)

Country Link
US (2) US10386374B2 (fr)
EP (3) EP3686597B1 (fr)
CA (1) CA2962931C (fr)
DK (1) DK3201624T3 (fr)
ES (1) ES3012582T3 (fr)
WO (1) WO2016054030A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3201624T3 (da) * 2014-09-30 2020-06-02 Siemens Healthcare Diagnostics Inc Indretning til detektion af hæmolyse, system og fremgangsmåde
US20210088502A1 (en) * 2017-12-20 2021-03-25 Radiometer Medical Aps In-vitro hemolysis detection and correction of at least one blood parameter in a whole blood sample
CA3108777C (fr) * 2018-08-06 2024-01-16 Siemens Healthcare Diagnostics Inc. Procede et dispositif pour determiner de la concentration d'analyte dans le sang total
JP2022510440A (ja) 2018-12-07 2022-01-26 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 流体構成成分評価機能を備えたデバイス
MX2021010738A (es) 2019-03-12 2021-09-28 Siemens Healthcare Diagnostics Inc Dispositivo de analisis de sangre para deteccion de hemolisis.
EP3983127B1 (fr) 2019-06-12 2025-04-23 Siemens Healthcare Diagnostics, Inc. Dispositif de séparation de plasma et de mesure d'échantillon et procédés d'utilisation associés
WO2021015808A1 (fr) 2019-07-19 2021-01-28 Siemens Healthcare Diagnostics Inc. Dispositif de test sanguin de détection d'hémolyse à écoulement tangentiel
EP4134670A1 (fr) * 2021-08-09 2023-02-15 Siemens Healthcare Diagnostics Inc. Analyseur d'hématologie comportant un module matériel unique et un flux de travail intégré
GB2620968B (en) * 2022-07-28 2025-07-30 Kalium Health Ltd Sensor, apparatus, kit and method
EP4659030A4 (fr) * 2023-01-30 2026-03-25 Siemens Healthcare Diagnostics Inc Méthodes et appareil de détection d'hémolyse

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010044A1 (fr) * 1993-10-04 1995-04-13 I-Stat Corporation Procede et appareil de detection d'hemolyse dans un echantillon de liquide
WO2011040874A1 (fr) * 2009-09-30 2011-04-07 Calmark Sweden Aktiebolag Système d'expérimentation pour déterminer un endommagement cellulaire induit par une hypoxie
WO2012036622A1 (fr) * 2010-09-14 2012-03-22 Calmark Sweden Ab Système et méthode permettant d'analyser le risque de survenue ou la présence effective d'une défaillance organique
US20120277697A1 (en) * 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
WO2013085462A1 (fr) * 2011-12-09 2013-06-13 Hemcheck Sweden Aktiebolag Système de détection d'hémolyse

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4274978A (en) 1979-12-07 1981-06-23 Abbott Laboratories Standards for determining glycosylated hemoglobin
US5296192A (en) * 1992-04-03 1994-03-22 Home Diagnostics, Inc. Diagnostic test strip
EP0805981A1 (fr) * 1995-01-25 1997-11-12 Therakos, Inc. Detecteur d'hemolyse jetable
SE9602298D0 (sv) 1996-06-11 1996-06-11 Siemens Elema Ab Arrangement for analysing body fluids
US6045899A (en) 1996-12-12 2000-04-04 Usf Filtration & Separations Group, Inc. Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
US5948695A (en) * 1997-06-17 1999-09-07 Mercury Diagnostics, Inc. Device for determination of an analyte in a body fluid
WO2002004947A2 (fr) 2000-07-12 2002-01-17 University Of South Florida Systeme spectrophotometrique et procede destine a identifier et caracteriser une particule dans un fluide corporel
US20030082076A1 (en) 2000-09-01 2003-05-01 Yueh-Hui Lin Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application
WO2003021255A1 (fr) * 2001-09-03 2003-03-13 Arkray, Inc. Instrument pour l'examen du sang
CA2504603C (fr) * 2002-11-19 2012-11-13 Sekisui Chemical Co., Ltd. Membrane de separation de plasma ou serum et appareil filtre comprenant la membrane de separation de plasma ou serum
US7379167B2 (en) 2003-02-11 2008-05-27 International Technidyne Corporation Hemoglobin test strip and analysis system
CA2507323A1 (fr) * 2005-05-13 2006-11-13 Chromedx Inc. Appareil de diagnostic pour l'analyse du plasma et du sang total
US8241915B2 (en) 2009-01-14 2012-08-14 Abbott Laboratories Methods and kits for detecting hemoglobin in test samples
EP2375249B1 (fr) * 2010-04-09 2019-12-25 F. Hoffmann-La Roche AG Dispositifs et procédé de séparation de plasma d'un échantillon sanguin
WO2011155897A1 (fr) * 2010-06-10 2011-12-15 Hemcheck Sweden Aktiebolag Dispositif de détection d'hémolyse
CN103874461B (zh) * 2011-04-29 2017-05-10 第七感生物系统有限公司 收集和/或操纵血斑或其他体液的装置
US20130084592A1 (en) 2011-10-04 2013-04-04 Siemens Healthcare Diagnostics Inc. Methods for correcting assay measurements
SE536430C2 (sv) * 2011-11-23 2013-10-29 Calmark Sweden Ab Testsystemarrangemang och metod för testning
US9188527B2 (en) 2013-01-09 2015-11-17 Molecular Devices, Llc Monochromator-based and filter-based detection system
DK3201624T3 (da) * 2014-09-30 2020-06-02 Siemens Healthcare Diagnostics Inc Indretning til detektion af hæmolyse, system og fremgangsmåde

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010044A1 (fr) * 1993-10-04 1995-04-13 I-Stat Corporation Procede et appareil de detection d'hemolyse dans un echantillon de liquide
WO2011040874A1 (fr) * 2009-09-30 2011-04-07 Calmark Sweden Aktiebolag Système d'expérimentation pour déterminer un endommagement cellulaire induit par une hypoxie
WO2012036622A1 (fr) * 2010-09-14 2012-03-22 Calmark Sweden Ab Système et méthode permettant d'analyser le risque de survenue ou la présence effective d'une défaillance organique
US20120277697A1 (en) * 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
WO2013085462A1 (fr) * 2011-12-09 2013-06-13 Hemcheck Sweden Aktiebolag Système de détection d'hémolyse

Also Published As

Publication number Publication date
EP3686597C0 (fr) 2024-10-30
EP3686597B1 (fr) 2024-10-30
DK3201624T3 (da) 2020-06-02
ES3012582T3 (en) 2025-04-09
EP4465017A3 (fr) 2025-01-22
US10386374B2 (en) 2019-08-20
CA2962931A1 (fr) 2016-04-07
US20170248618A1 (en) 2017-08-31
EP3686597A1 (fr) 2020-07-29
US10670614B2 (en) 2020-06-02
EP3201624B1 (fr) 2020-03-11
EP3201624A1 (fr) 2017-08-09
CA2962931C (fr) 2021-12-14
EP4465017A2 (fr) 2024-11-20
WO2016054030A1 (fr) 2016-04-07
US20190339293A1 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
EP3142072A4 (fr) Dispositif, procédé et système de détection d'objets
EP3187852A4 (fr) Système de détection d'odeurs, dispositif d'identification d'odeurs, et procédé d'identification d'odeurs
EP3118752A4 (fr) Procédé, système et dispositif de recherche
EP3193238A4 (fr) Dispositif de détection, procédé de détection, dispositif de commande et procédé de commande
EP3144839A4 (fr) Dispositif de détection, procédé de détection et programme de détection
EP3091778A4 (fr) Méthode de mesure, procédé de configuration, dispositif et système associés
EP3177029A4 (fr) Procédé, dispositif et système de traitement de signal
EP3107347A4 (fr) Dispositif de traitement d'informations, système de traitement d'informations et procédé de traitement d'informations
EP3139297A4 (fr) Dispositif de détermination de logiciel malveillant, système de détermination de logiciel malveillant, procédé de détermination de logiciel malveillant, et programme
EP3166311A4 (fr) Dispositif de traitement de signal, procédé de traitement de signal, et dispositif de surveillance
EP3141432A4 (fr) Dispositif, système et procédé d'inspection
EP3343202A4 (fr) Dispositif de détection de substance, système de détection de substance, et procédé de détection de substance
EP3098697A4 (fr) Dispositif de détection de position, système de détection de position et procédé de détection de position
EP3146332A4 (fr) Procédé et système de détection d'hémolyse
EP3119098A4 (fr) Dispositif de traitement d'informations, système de traitement d'informations, et procédé de traitement d'informations
EP3170036A4 (fr) Système, procédé et dispositif de détection de la foudre
EP3210541A4 (fr) Procédé et dispositif pour sélectionner une zone de détection et système de détection d'élasticité
EP3156898A4 (fr) Procédé, dispositif et système de traitement d'informations
EP3211590A4 (fr) Dispositif d'amélioration d'habitudes de vie, procédé d'amélioration d'habitudes de vie, et système d'amélioration d'habitudes de vie
EP3201624A4 (fr) Dispositif, système et procédé de détection d'hémolyse
EP3171156A4 (fr) Système de détection et procédé de détection
EP3115981A4 (fr) Système de réponse en cas de catastrophe, procédé de réponse en cas de catastrophe, dispositif de détection de catastrophe, et procédé de traitement associé
EP3392792A4 (fr) Dispositif, système et procédé d'évaluation
EP3109674A4 (fr) Dispositif de détection de déplacement de structure, système de partage d'un déplacement de structure, procédé de détection de déplacement de structure et programme de détection de déplacement de structure
EP3128804A4 (fr) Procédé, dispositif et système de détection de communication de dispositif à dispositif (d2d)

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602015048750

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: G01N0033483000

Ipc: G01N0033490000

17P Request for examination filed

Effective date: 20170502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20170801

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/49 20060101AFI20170726BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180424

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190930

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1243779

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200315

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015048750

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20200528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200611

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200311

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200612

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200611

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200711

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200805

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1243779

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200311

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015048750

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

26N No opposition filed

Effective date: 20201214

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: SIEMENS SCHWEIZ AG, CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200929

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602015048750

Country of ref document: DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20250923

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20251120

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20251002

Year of fee payment: 11